
Caza Health: A biotech firm specializing in women's health, microbiome, immunology, and oncology.
Caza Health, founded with a mission to revolutionize women's health through advanced biotechnology, focuses on the microbiome, immunology, and oncology. The company is dedicated to addressing unaddressed women's health issues by developing rapid, accurate AI-driven point-of-care diagnostics. Their flagship product assesses the vaginal microbiome, aiming to provide comprehensive and accessible diagnostics solutions for women.
Notable figures affiliated with Caza Health include leading experts in biotechnology and women's health. The company has garnered attention from prominent investors in the biotech sector. Key achievements include the development of a fluorescent scanning technology for diagnostics, which has the potential to significantly improve the accuracy and speed of women's health diagnostics. Caza Health's impact lies in its innovative approach to solving critical health issues, promising better healthcare outcomes for women globally.

Biomirror Diagnostics

Nanopath
nanopathdx.com

Hera Biotech
herabiotech.com

Caire Health
cairehealth.com

Luca Biologics
seedhealth.com

Caspr

OncoHealth
oncohealthcorp.com

Caia

Axena Health
axenahealth.com

Aspira Women's Health
aspirawh.com

Prompt Diagnostics
prompt-dx.com

Cue Health
cuehealth.com

Cayaba Care
cayabacare.com

Jona
jona.health

Ovagene Oncology
Companies similar to Caza Health include Biomirror Diagnostics, Nanopath, Hera Biotech and Caire Health.
Caza Health was founded in 2019.
Caza Health's headquarters is located in Earlysville, VA, US.
Caza Health's most recent funding round was for $249.7k (USD) in August 2020.
As of Aug 26, 2020, Caza Health has raised a total of $249.7k (USD).
Caza Health has 9 employees as of Feb 4, 2024.